XaTek Inc. receives key FDA designation to aid commercialization of its ClotChip device

XaTek Inc., a clinical-stage diagnostic device company based in Cleveland, said it has received Breakthrough Device designation from the U.S. Food and Drug Administration for its ClotChip technology.

Publisher Name
Crain's Cleveland Business